Roche Takes SCENIC Route On Genetic Modifiers

Deal Could Be Worth Up To $375m

 
• By Kevin Grogan
  
Genetic_Modifier
Scenic is a pioneer in genetic modifiers • Source: Scenic Biotech
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business